No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CRVO CervoMed
- 24.990
- +1.170+4.91%
Trading Apr 29 10:18 ET
154.20MMarket Cap-65248P/E (TTM)
24.990High24.990Low2.11KVolume24.990Open23.820Pre Close52.63KTurnover0.09%Turnover RatioLossP/E (Static)6.17MShares26.37952wk High20.91P/B61.63MFloat Cap4.14052wk Low--Dividend TTM2.47MShs Float3375000000.000Historical High--Div YieldTTM0.00%Amplitude4.140Historical Low24.990Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
CervoMed Updates Stakeholders on Clinical and Financial Status
CervoMed Is Maintained at Buy by Canaccord Genuity
CervoMed Is Maintained at Buy by Canaccord Genuity
Canadian Investment Banking Group: Maintaining the CervOmed (CRVO.US) rating, adjusted from buy to buy rating, and adjusted the target price from $50.00 to $65.00.
Canadian Investment Banking Group: Maintaining the CervOmed (CRVO.US) rating, adjusted from buy to buy rating, and adjusted the target price from $50.00 to $65.00.
Canaccord Genuity Maintains Buy on CervoMed, Raises Price Target to $65
Canaccord Genuity analyst Sumant Kulkarni maintains CervoMed with a Buy and raises the price target from $50 to $65.
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), CervoMed (CRVO) and Teladoc (TDOC)
CervoMed Shares Operational and Financial Insights Online
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg